Patient Council as a Service.

Why this exists

Ad-hoc patient consultation, one workshop, one advisory board, is not repeatable and not auditable. JCA patient-input files, MHRA Inclusion and Diversity Plans, and NIHR INCLUDE grant reviews all now expect a standing, documented patient-input function, not a one-off touchpoint.

Pharma leadership is naming the gap in public. Patient experience is now framed across the industry as the layer that structured clinical data alone cannot capture, and patient-community partnership as the mechanism through which barriers and unmet needs become visible. That is the standard everyone is being measured against.

Patient Council as a Service is the operational version of that standard, run for you, from the Equity Engine panel and community-partner network already in place.

Not just a meeting cadence: an evidence-enriched council

Most patient councils are a schedule of meetings and a set of minutes. Ours is different because it sits on top of the Equity Engine dataset. Every question your council debates is grounded in real longitudinal patient experience data from the community it represents, video diaries, voice notes, longitudinal surveys, focus groups and lived-experience narratives, all AI-analysed and synthesised.

That means the council is not just opinion. It is opinion informed by ongoing evidence from the same populations. When the council makes a recommendation on protocol design, label language, or PMCF strategy, that recommendation is auditable to the data behind it.

The impact: recommendations that hold up under HTA challenge, protocol amendments avoided because the council flagged an issue before submission, and a decision record that regulators, boards and community partners can all inspect.

What is included, entry tier

• Single therapy area coverage
• Four Patient Council meetings a year
• Between-meeting evidence briefings drawing on the Equity Engine dataset for the represented community
• Community-partner-recruited members, matched to your therapy area
• Written meeting record and action log, cross-referenced to the underlying data
• Assigned Unwritten Health facilitator and lead analyst

What is included, top tier

• Multi-therapy coverage across your medical-affairs portfolio
• Monthly cadence, with continuous evidence enrichment between meetings
• On-demand query response, 5 business days turnaround, backed by the panel
• Quarterly written-report summary for board and HTA teams, tying council recommendations to the underlying evidence base
• Bespoke video-diary and voice-note prompts commissioned between meetings on your priority questions
• Dedicated council manager and analyst
• Direct integration with your JCA, HTA and PMCF workstreams

What is not included

• Compensation for individual participants beyond NIHR guide rates, we run at NIHR rates as our baseline
• Bespoke event management (external launches, congress panels), scoped separately

How it works

Weeks 1 to 4. Council composition. We recruit members through community partners already in the panel, matched to your therapy area and target subgroups.

Between meetings. Evidence briefings from the Equity Engine dataset go to council members on the questions ahead. Members bring lived experience; we bring the longitudinal data that anchors it.

Ongoing. Council operates on the cadence you have selected. Every meeting has a written record and action log tied to the underlying data. Every on-demand query has a written response.

Annually. Refresh cycle. Board-level summary of decisions influenced, tied to outcomes.

Why an annual engagement

A one-off pharma advisory-board event delivers a single insight moment. Patient Council as a Service delivers continuous, repeatable, auditable, data-anchored patient input at the annual budget line of one such event.